Number of Patients, Male	48
Number of Patients, Female	8
Stage	IIIA, 30; IIIB, 26
Age	Median (range): 66 (45–74)
Number of Prior Systemic Therapies	Median (range): 0
Performance Status: ECOG	0 — 26 1 — 30 2 — 0 3 — 0 Unknown — 0
Other	Smoking status: Never, 6; Former 50 EGFR mutation status: Negative, 32; Positive, 6; Unknown, 18 ALK fusion status: Negative, 25; Positive, 1; Unknown, 30
Cancer Types or Histologic Subtypes	Adenocarcinoma, 30 Squamous cell carcinoma, 23 Other, 3